BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32109311)

  • 21. Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note.
    Paez-Ribes M; Man S; Xu P; Kerbel RS
    PLoS One; 2016; 11(6):e0158034. PubMed ID: 27355476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer.
    Goetz MP; Kalari KR; Suman VJ; Moyer AM; Yu J; Visscher DW; Dockter TJ; Vedell PT; Sinnwell JP; Tang X; Thompson KJ; McLaughlin SA; Moreno-Aspitia A; Copland JA; Northfelt DW; Gray RJ; Hunt K; Conners A; Sicotte H; Eckel-Passow JE; Kocher JP; Ingle JN; Ellingson MS; McDonough M; Wieben ED; Weinshilboum R; Wang L; Boughey JC
    J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical and Oncological Factors Affecting the Successful Engraftment of Patient-derived Xenografts in Pancreatic Ductal Adenocarcinoma.
    Jun E; Jung J; Jeong SY; Choi EK; Kim MB; Lee JS; Hong SM; Seol HS; Hwang C; Hoffman RM; Shim IK; Chang S; Kim SC
    Anticancer Res; 2016 Feb; 36(2):517-21. PubMed ID: 26851005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations.
    Nanni P; Landuzzi L; Manara MC; Righi A; Nicoletti G; Cristalli C; Pasello M; Parra A; Carrabotta M; Ferracin M; Palladini A; Ianzano ML; Giusti V; Ruzzi F; Magnani M; Donati DM; Picci P; Lollini PL; Scotlandi K
    Sci Rep; 2019 Aug; 9(1):12174. PubMed ID: 31434953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models.
    Zhang X; Claerhout S; Prat A; Dobrolecki LE; Petrovic I; Lai Q; Landis MD; Wiechmann L; Schiff R; Giuliano M; Wong H; Fuqua SW; Contreras A; Gutierrez C; Huang J; Mao S; Pavlick AC; Froehlich AM; Wu MF; Tsimelzon A; Hilsenbeck SG; Chen ES; Zuloaga P; Shaw CA; Rimawi MF; Perou CM; Mills GB; Chang JC; Lewis MT
    Cancer Res; 2013 Aug; 73(15):4885-97. PubMed ID: 23737486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the treatment strategies on patient-derived xenograft mice of human breast tumor.
    Khalighfard S; Alizadeh AM; Poorkhani A; Motahari M; Tahmasebifar A; Omranipour R; Keshavarz P; Haddad P
    Eur J Pharmacol; 2020 Dec; 889():173605. PubMed ID: 32980347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived Xenografts.
    Kuwata T; Yanagihara K; Iino Y; Komatsu T; Ochiai A; Sekine S; Taniguchi H; Katai H; Kinoshita T; Ohtsu A
    Cells; 2019 Jun; 8(6):. PubMed ID: 31207870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncological and genetic factors impacting PDX model construction with NSG mice in pancreatic cancer.
    Guo S; Gao S; Liu R; Shen J; Shi X; Bai S; Wang H; Zheng K; Shao Z; Liang C; Peng S; Jin G
    FASEB J; 2019 Jan; 33(1):873-884. PubMed ID: 30091943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of a Patient-Derived Tumor Xenograft Model and Application for Precision Cancer Medicine.
    Okada S; Vaeteewoottacharn K; Kariya R
    Chem Pharm Bull (Tokyo); 2018; 66(3):225-230. PubMed ID: 29491256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orthotopic Patient-Derived Pancreatic Cancer Xenografts Engraft Into the Pancreatic Parenchyma, Metastasize, and Induce Muscle Wasting to Recapitulate the Human Disease.
    Go KL; Delitto D; Judge SM; Gerber MH; George TJ; Behrns KE; Hughes SJ; Judge AR; Trevino JG
    Pancreas; 2017 Jul; 46(6):813-819. PubMed ID: 28609371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of a Liver Orthotopic Human Uveal Melanoma Xenograft Platform in Immunodeficient Mice.
    Kageyama K; Ozaki S; Sato T
    J Vis Exp; 2019 Nov; (153):. PubMed ID: 31762467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor.
    Sicklick JK; Leonard SY; Babicky ML; Tang CM; Mose ES; French RP; Jaquish DV; Hoh CK; Peterson M; Schwab R; Lowy AM
    J Transl Med; 2014 Feb; 12():41. PubMed ID: 24507750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies.
    Jäger W; Xue H; Hayashi T; Janssen C; Awrey S; Wyatt AW; Anderson S; Moskalev I; Haegert A; Alshalalfa M; Erho N; Davicioni E; Fazli L; Li E; Collins C; Wang Y; Black PC
    Oncotarget; 2015 Aug; 6(25):21522-32. PubMed ID: 26041878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples.
    Dong Y; Manley BJ; Becerra MF; Redzematovic A; Casuscelli J; Tennenbaum DM; Reznik E; Han S; Benfante N; Chen YB; Arcila ME; Aras O; Voss MH; Feldman DR; Motzer RJ; Fabbri N; Healey JH; Boland PJ; Chawla M; Durack JC; Lee CH; Coleman JA; Russo P; Hakimi AA; Cheng EH; Hsieh JJ
    Eur Urol Focus; 2017 Dec; 3(6):590-598. PubMed ID: 28753786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defining the boundaries and expanding the utility of head and neck cancer patient derived xenografts.
    Swick AD; Stein AP; McCulloch TM; Hartig GK; Ong IM; Sampene E; Prabakaran PJ; Liu CZ; Kimple RJ
    Oral Oncol; 2017 Jan; 64():65-72. PubMed ID: 28024726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
    Wang D; Pham NA; Tong J; Sakashita S; Allo G; Kim L; Yanagawa N; Raghavan V; Wei Y; To C; Trinh QM; Starmans MH; Chan-Seng-Yue MA; Chadwick D; Li L; Zhu CQ; Liu N; Li M; Lee S; Ignatchenko V; Strumpf D; Taylor P; Moghal N; Liu G; Boutros PC; Kislinger T; Pintilie M; Jurisica I; Shepherd FA; McPherson JD; Muthuswamy L; Moran MF; Tsao MS
    Int J Cancer; 2017 Feb; 140(3):662-673. PubMed ID: 27750381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of Natural Killer Cell Infiltration on the Growth of Breast Cancer Patient-Derived Tumor Xenografts].
    Mukohyama J; Shimono Y; Funakoshi Y; Kono S; Yamashita K; Mukohara T; Takao S; Minami H; Kakeji Y
    Gan To Kagaku Ryoho; 2015 Oct; 42(10):1252-5. PubMed ID: 26489563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice.
    Kim MP; Evans DB; Wang H; Abbruzzese JL; Fleming JB; Gallick GE
    Nat Protoc; 2009; 4(11):1670-80. PubMed ID: 19876027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Vivo Isolation of a Highly-aggressive Variant of Triple-negative Human Breast Cancer MDA-MB-231 Using Serial Orthotopic Transplantation.
    Yano S; Takehara K; Miwa S; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
    Anticancer Res; 2016 Aug; 36(8):3817-20. PubMed ID: 27466482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.